Thank you very much;
you're only a step away from
downloading your reports.
Allergan Case Study: Take Profits After Getting Lucky in a Stock
After my 23% gain in Allergan, I've decided to sell shares.
Brandon Perry    

This article was originally posted on the Buzz & Banter where subscribers can follow over 30 professional traders as they share their ideas in real time. Want access to the Buzz plus unlimited market commentary? Click here to learn more about MVPRO+.

I had no idea that a buyout offer was coming for Allergan (NYSE:AGN). What I did see was a stock acting funny in the midst of a sector sell-off. This was the clue that tipped my hand to hitting the buy button on Allergan last week [subscription required].

To summarize, I wrote:

This is a nice health care stock that has the momentum characteristics that I like. It held much higher while the sky was falling for much of its space. It rocketed to new all-time highs today and isn't overbought. From the fundamental side, it is making money, increasing free cash flow. The stock is cheap on a relative basis to its peers, and it has low debt and a decent pipeline.

Now, three trading days later, I sit with a decision to make. Do I take an approximately 23% gain today or hold out for the counter offer?

It is tempting to be the hero and try for the "Top Tick Trophy," however that is neither my mode nor my style.

I am content with a three-day, 23% gain, so I am selling my shares of Allergan. When I get an unexpected profit like this, I prefer to reflect on my process.

What I try to do is buy quality companies at technically appropriate times and sometimes it leads me to lucky spots like this. After I sell my shares of Allergan, I will look to redeploy the cash in other areas. I have a nice list of additional opportunities that I will share at a later time.

< Previous
  • 1
Next >
Position in AGN
Allergan Case Study: Take Profits After Getting Lucky in a Stock
After my 23% gain in Allergan, I've decided to sell shares.
Brandon Perry    

This article was originally posted on the Buzz & Banter where subscribers can follow over 30 professional traders as they share their ideas in real time. Want access to the Buzz plus unlimited market commentary? Click here to learn more about MVPRO+.

I had no idea that a buyout offer was coming for Allergan (NYSE:AGN). What I did see was a stock acting funny in the midst of a sector sell-off. This was the clue that tipped my hand to hitting the buy button on Allergan last week [subscription required].

To summarize, I wrote:

This is a nice health care stock that has the momentum characteristics that I like. It held much higher while the sky was falling for much of its space. It rocketed to new all-time highs today and isn't overbought. From the fundamental side, it is making money, increasing free cash flow. The stock is cheap on a relative basis to its peers, and it has low debt and a decent pipeline.

Now, three trading days later, I sit with a decision to make. Do I take an approximately 23% gain today or hold out for the counter offer?

It is tempting to be the hero and try for the "Top Tick Trophy," however that is neither my mode nor my style.

I am content with a three-day, 23% gain, so I am selling my shares of Allergan. When I get an unexpected profit like this, I prefer to reflect on my process.

What I try to do is buy quality companies at technically appropriate times and sometimes it leads me to lucky spots like this. After I sell my shares of Allergan, I will look to redeploy the cash in other areas. I have a nice list of additional opportunities that I will share at a later time.

< Previous
  • 1
Next >
Position in AGN
More From Brandon Perry
Allergan Case Study: Take Profits After Getting Lucky in a Stock
After my 23% gain in Allergan, I've decided to sell shares.
Brandon Perry    

This article was originally posted on the Buzz & Banter where subscribers can follow over 30 professional traders as they share their ideas in real time. Want access to the Buzz plus unlimited market commentary? Click here to learn more about MVPRO+.

I had no idea that a buyout offer was coming for Allergan (NYSE:AGN). What I did see was a stock acting funny in the midst of a sector sell-off. This was the clue that tipped my hand to hitting the buy button on Allergan last week [subscription required].

To summarize, I wrote:

This is a nice health care stock that has the momentum characteristics that I like. It held much higher while the sky was falling for much of its space. It rocketed to new all-time highs today and isn't overbought. From the fundamental side, it is making money, increasing free cash flow. The stock is cheap on a relative basis to its peers, and it has low debt and a decent pipeline.

Now, three trading days later, I sit with a decision to make. Do I take an approximately 23% gain today or hold out for the counter offer?

It is tempting to be the hero and try for the "Top Tick Trophy," however that is neither my mode nor my style.

I am content with a three-day, 23% gain, so I am selling my shares of Allergan. When I get an unexpected profit like this, I prefer to reflect on my process.

What I try to do is buy quality companies at technically appropriate times and sometimes it leads me to lucky spots like this. After I sell my shares of Allergan, I will look to redeploy the cash in other areas. I have a nice list of additional opportunities that I will share at a later time.

< Previous
  • 1
Next >
Position in AGN
EDITOR'S PICKS
 
WHAT'S POPULAR